Alternating hemiplegia of childhood: genes and variants
Explore variant evidence for Alternating hemiplegia of childhood across 2 analyzed proteins (ATP1A3, ATP1A2). Linked ClinVar records include 30 pathogenic or likely pathogenic variants, 29 variants of uncertain significance and 10 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Alternating hemiplegia of childhood
ATP1A3: Sodium/potassium-transporting ATPase subunit alpha-3
It rapidly restores neuronal sodium and potassium gradients after repetitive firing, making it particularly important in highly active neurons. Pathogenic variants cause overlapping syndromes including alternating hemiplegia of childhood, rapid-onset dystonia-parkinsonism, and CAPOS syndrome.
23 ClinVar pathogenic / likely pathogenic and 16 uncertain variants in ATP1A3 have source records linked to Alternating hemiplegia of childhood. Association strength is not clinical gene validity.
ATP1A2: Sodium/potassium-transporting ATPase subunit alpha-2
It restores sodium and potassium gradients after activity in astrocytes and other excitable tissues and thereby supports neuronal ion homeostasis. Pathogenic variants are a major cause of familial hemiplegic migraine type 2 and can produce severe episodic neurologic disease.
7 ClinVar pathogenic / likely pathogenic and 23 uncertain variants in ATP1A2 have source records linked to Alternating hemiplegia of childhood. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Alternating hemiplegia of childhood
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| ATP1A3 R756C | 756 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ATP1A3 D801N | 801 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| ATP1A3 G947R | 947 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| ATP1A3 G947W | 947 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| ATP1A3 G947E | 947 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| ATP1A2 R383H | 383 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ATP1A2 G615R | 615 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ATP1A3 V129M | 129 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| ATP1A3 I318M | 318 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| ATP1A3 G358D | 358 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ATP1A3 D609Y | 609 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ATP1A3 T613M | 613 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ATP1A3 N773S | 773 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| ATP1A3 I777N | 777 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| ATP1A2 R937C | 937 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ATP1A2 I293M | 293 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| ATP1A2 T378N | 378 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ATP1A2 G855R | 855 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| ATP1A3 S137F | 137 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| ATP1A3 T360R | 360 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ATP1A3 R756S | 756 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| ATP1A3 D801H | 801 | Transmembrane | Pathogenic / likely pathogenic (★) |
| ATP1A3 C333Y | 333 | Transmembrane | Pathogenic / likely pathogenic (★) |
| ATP1A3 Q920R | 920 | Transmembrane | Pathogenic / likely pathogenic (★) |
| ATP1A2 S779N | 779 | Transmembrane | Pathogenic / likely pathogenic (★) |
| ATP1A3 T331P | 331 | Transmembrane | Pathogenic / likely pathogenic (★) |
| ATP1A3 T335K | 335 | Transmembrane | Pathogenic / likely pathogenic (★) |
| ATP1A3 C364R | 364 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| ATP1A3 A843D | 843 | Transmembrane | Pathogenic / likely pathogenic (★) |
| ATP1A3 E389K | 389 | Cytoplasmic | Pathogenic / likely pathogenic |
Which prediction tools work for Alternating hemiplegia of childhood
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- CATVariant: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 97 out of 100
- MutPred: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 95 out of 100
- MetaSVM: 95 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 94 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 92 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 91 out of 100
Same protein, different disease
- Cerebellar ataxia - areflexia - pes cavus - optic atrophy - sensorineural hearing loss also has ClinVar records linked to ATP1A3 variants; they fall mostly in different places as the Alternating hemiplegia of childhood variants (18 pathogenic / likely pathogenic).
- Developmental and epileptic encephalopathy also has ClinVar records linked to ATP1A3 variants; they fall mostly in different places as the Alternating hemiplegia of childhood variants (17 pathogenic / likely pathogenic).
- ATP1A3-associated neurological disorder also has ClinVar records linked to ATP1A3 variants; they fall in the same places as the Alternating hemiplegia of childhood variants (4 pathogenic / likely pathogenic).
- Familial hemiplegic migraine also has ClinVar records linked to ATP1A2 variants; they fall mostly in different places as the Alternating hemiplegia of childhood variants (45 pathogenic / likely pathogenic).
- Developmental and epileptic encephalopathy also has ClinVar records linked to ATP1A2 variants; they fall mostly in different places as the Alternating hemiplegia of childhood variants (8 pathogenic / likely pathogenic).
Diseases related to Alternating hemiplegia of childhood
- Developmental and epileptic encephalopathy, also linked to ATP1A2 and ATP1A3
- Familial hemiplegic migraine, also linked to ATP1A2
- Cerebellar ataxia - areflexia - pes cavus - optic atrophy - sensorineural hearing loss, also linked to ATP1A3
- ATP1A3-associated neurological disorder, also linked to ATP1A3
- Hereditary ataxia, also linked to ATP1A3
Frequently asked questions
Which genes have records linked to Alternating hemiplegia of childhood?
This view contains 2 analyzed proteins: ATP1A3, ATP1A2. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 30 pathogenic or likely pathogenic variants, 29 variants of uncertain significance and 10 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 97 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center